A label-first guide to Pinus pinaster, procyanidins, human research, the licensed Canadian dose and the difference between a botanical extract and a trademarked ingredient.

What is maritime pine bark extract?

Maritime pine, or Pinus pinaster, is a pine species native to the western Mediterranean region. Its bark contains polyphenolic compounds, especially procyanidins. A supplement concentrates those compounds into an extract, which means it is not interchangeable with pine needles, pine essential oil, pine pollen or food made from pine nuts.

The Biogénique formula uses 200 mg of Pinus pinaster per capsule and standardizes the extract to 65% procyanidins. Standardization is useful because it sets a target for a named constituent. At 65%, one 200 mg capsule supplies 130 mg of standardized procyanidins; the labelled two-capsule day supplies 260 mg. Standardization describes composition—it does not guarantee a particular clinical result.

What do procyanidins do?

Procyanidins are chains built from flavan-3-ol units such as catechin and epicatechin. They occur in foods including cocoa, apples, grapes and some berries. In laboratory systems they can participate in antioxidant chemistry, while digestion and the gut microbiome transform larger molecules into metabolites that may behave differently in the body.

That distinction matters. A test-tube antioxidant result is not proof that a supplement prevents disease. For this finished product, the compliant conclusion comes from its Canadian licence: it provides antioxidants that help protect cells against oxidative damage caused by free radicals.[1] Broader health outcomes require separate human evidence.

Is pine bark extract the same as Pycnogenol?

No. Pycnogenol is a trademarked, proprietary French maritime pine bark extract with its own manufacturing specifications and clinical research. A product can use the same species and have a similar procyanidin percentage without being that proprietary ingredient. Plant part, extraction solvent, fraction profile, analytical method and other specifications can still differ.

Biogénique identifies its ingredient as Pinus pinaster bark extract standardized to 65% procyanidins; it does not identify the medicinal ingredient as Pycnogenol. Therefore, a Pycnogenol trial is indirect background evidence—not proof that the Biogénique product will reproduce the same effect. Calling it a ‘generic Pycnogenol’ would overstate equivalence.

What benefits are actually supported?

1. Antioxidant support: the licensed use

Health Canada’s active licence for NPN 80136598 lists one finished-product purpose: a source of antioxidants that helps protect cells against oxidative damage caused by free radicals. The licence also verifies the ingredient amount, 65% procyanidin standardization and adult dose.[1] This is the most direct evidence for how the exact product may be presented in Canada.

An antioxidant claim should remain modest. Oxidative processes are part of normal biology, and an antioxidant supplement has not automatically been shown to prevent heart disease, reverse ageing or treat a chronic condition. The NPN confirms that Health Canada reviewed the product for its labelled conditions of use; it does not promise an individual outcome.

2. Circulation and endothelial function: an early signal

A randomized, double-blind crossover study enrolled 23 adults with stable coronary artery disease. Participants received 200 mg per day of Pycnogenol or placebo for eight weeks, then crossed over after a washout. Flow-mediated dilation, a research measure of endothelial function, improved during the proprietary extract period, and one oxidative-stress marker decreased. Blood pressure, inflammatory markers and platelet adhesion did not change.[3]

The study is interesting because it was controlled and used a dose numerically similar to one Biogénique capsule. It is not a reason to treat vascular disease with this product. The trial was small, short, conducted in patients receiving standard cardiovascular therapy, and tested a named proprietary extract. Flow-mediated dilation is also a surrogate measure, not a heart-attack or stroke outcome.

Older small studies have explored Pycnogenol for symptoms of chronic venous insufficiency, such as leg heaviness and swelling. The 2020 Cochrane review evaluated pine-bark supplements across 27 randomized trials and 10 chronic disorders, including cardiovascular risk and venous insufficiency. It rated the evidence as very uncertain and found the available data insufficient for firm efficacy or safety conclusions.[2] Compression therapy, movement, medical assessment and prescribed treatment should not be displaced by a supplement.

3. Blood pressure and cardiometabolic claims: not established

Pine-bark marketing often extends from ‘circulation’ to blood pressure. A meta-analysis limited to seven randomized double-blind placebo-controlled Pycnogenol trials, with 626 participants, found no significant improvement in systolic or diastolic blood pressure.[4] Other reviews have pooled different trials and reported small changes, which illustrates how conclusions vary with study selection and methods.

The practical message is straightforward: Biogénique Maritime Pine Bark Extract is not licensed as a blood-pressure or glucose treatment, and it should not be used to delay diagnosis or replace medication. Blood pressure and glucose can improve or worsen without obvious symptoms; use validated measurements and clinician-guided follow-up instead of how a supplement feels.

4. Skin and collagen: suggestive, not proven

A 12-week study followed 20 healthy postmenopausal women taking Pycnogenol and reported improvements in skin hydration and elasticity alongside changes in gene-expression markers related to hyaluronic acid and collagen.[5] The biological story is appealing, but the study had no placebo group and only 20 participants. Time, season, skincare, hydration and measurement variability could contribute to change.

This evidence is too weak to promise firmer skin or more collagen from the Biogénique extract. If skin health is the goal, sun protection, smoking avoidance, adequate nutrition and appropriate dermatologic care have clearer roles. Pine-bark research can be described as exploratory, not as a cosmetic guarantee.

How to take the Biogénique product

The licensed direction is for adults 18 years and older to take one capsule twice daily. That equals 400 mg of Pinus pinaster extract and 260 mg of standardized procyanidins per labelled day.[1] Follow the current package rather than copying a dose from a Pycnogenol, Oligopin or other pine-bark study; those preparations are not automatically interchangeable.

The licence does not specify a time of day, a required meal or a defined treatment duration. Consistency makes tolerance easier to assess. If a capsule causes stomach discomfort, stop and ask a pharmacist or clinician whether food, timing or discontinuation is appropriate. Do not double a missed dose unless the current label or a health professional specifically instructs you to do so.

Side effects, cautions and interactions

The current Health Canada API record returns no product-specific caution, contraindication or known-adverse-reaction text for NPN 80136598.[1] An empty risk field does not mean zero risk. Trials are generally small and short, adverse events can be under-detected, and another person’s review does not establish safety for you.

Published pine-bark studies and mechanistic literature have examined vascular function, platelet activity, glucose and immune pathways. That does not prove a clinically important interaction, but it makes professional review prudent if you take anticoagulant or antiplatelet drugs, blood-pressure medicine, diabetes medicine or immunosuppressive therapy; have a bleeding disorder, autoimmune condition or significant liver or kidney disease; or are preparing for surgery or a procedure.

The licensed dose is adult-only. Pregnancy and breastfeeding data are limited, so ask a qualified health professional before use. Stop the product and seek care for a suspected allergic reaction, unusual bleeding, fainting, severe or persistent gastrointestinal symptoms, or any new symptom that could represent a medical problem.

A supplement is not an acute treatment. Chest pressure, sudden shortness of breath, one-sided weakness, trouble speaking, severe leg swelling or a hot, painful limb requires prompt medical assessment rather than another capsule.

How to assess product quality

Start with identity. NPN 80136598 is active and matches Biogenique Maritime Pine Bark Extract, 200 mg per capsule, standardized to 65% procyanidins. The licensed non-medicinal ingredients are rice flour and hypromellose.[1] The live product page offers 60- and 120-capsule sizes.[6] Check the package in hand because online details and formulations can change.

Next, separate licensing from lot testing. An NPN verifies a licensed formulation and conditions of use; it is not a certificate for the bottle’s manufacturing lot. A useful certificate of analysis should identify the product and lot and report relevant methods, specifications and results. No matching product-specific COA was available in the reviewed Drive folders, so this article makes no batch-level purity, potency, heavy-metal, microbial or ‘tested every batch’ statement.

Frequently asked questions

What is maritime pine bark extract used for?

For this exact product in Canada, the licensed use is antioxidant support: helping protect cells against oxidative damage caused by free radicals. Research has explored many other outcomes, but the evidence is too uncertain to treat those as finished-product promises.

Is 65% procyanidins the same as 65% Pycnogenol?

No. Procyanidin standardization describes one part of an extract. Pycnogenol is a proprietary ingredient defined by more than one percentage. Similarity in species or procyanidin content does not establish clinical equivalence.

How many milligrams are in the daily dose?

One capsule contains 200 mg of extract and 130 mg of standardized procyanidins. The adult label calls for one capsule twice daily: 400 mg of extract and 260 mg of standardized procyanidins per day.

Does pine bark extract lower blood pressure?

It is not licensed for that purpose, and a meta-analysis of seven double-blind placebo-controlled Pycnogenol trials did not find a significant blood-pressure benefit. Do not change prescribed treatment or monitoring.

How long does it take to work?

The antioxidant licence does not promise a sensation or timeline. Research periods often last several weeks, but studies use different extracts and outcomes. Feeling different is not a reliable measure of blood pressure, glucose or vascular health.

Can I take it with other supplements or medicines?

There is no universal yes-or-no answer. Ask a pharmacist or clinician to review the whole list, especially products or medicines that affect bleeding, blood pressure, glucose or immune function.

The bottom line

Maritime pine bark extract is a procyanidin-rich botanical with a clear antioxidant rationale and a broad—but uneven—research history. The strongest product-specific statement is the Canadian licence: Biogénique NPN 80136598 provides 200 mg of Pinus pinaster standardized to 65% procyanidins per capsule and is licensed as an antioxidant source.

Condition-specific benefits should be treated cautiously. Most trials used proprietary extracts, the major Cochrane review rated the evidence very uncertain, and standardization alone does not make this product Pycnogenol-equivalent. Follow the adult label, keep established care in place, review medicines and health conditions with a professional, and look for lot-specific documentation before accepting batch-quality claims.

Product link

View Biogénique Maritime Pine Bark Extract product details

Sources

[1] Health Canada. Licensed Natural Health Products Database API — NPN 80136598

[2] Robertson NU, et al. (2020). Pine bark (Pinus spp.) extract for treating chronic disorders — Cochrane review

[3] Enseleit F, et al. (2012). Effects of Pycnogenol on endothelial function in stable coronary artery disease

[4] Pourmasoumi M, et al. (2020). Effect of Pycnogenol on blood pressure: systematic review and meta-analysis

[5] Marini A, et al. (2012). Pycnogenol effects on skin elasticity and hydration

[6] Biogénique. Maritime Pine Bark Extract product page

[7] Health Canada. Licensed Natural Health Products Database API guide

IMPORTANT — Educational information only; not medical advice. Claims, directions and risk statements are product- and licence-specific. Read the current label and seek appropriate professional care for symptoms or chronic-condition management.